Perioperative Finotonlimab Plus Chemotherapy in Untreated Stage II HNSCC

NCT07751276 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma HNSCC

Interventions

DRUG: Neoadjuvant Finotonlimab Plus Chemotherapy
PROCEDURE: Surgery
DRUG: Postoperative Finotonlimab Maintenance

Sponsor

Yanjie Zhang, MD